Početna › Intersticijske bolesti pluća › Colorado
Kliničke studije za Intersticijske bolesti pluća u državi Colorado
15 studija za Intersticijske bolesti pluća traži sudionike na lokacijama u državi Colorado.
Gradovi u državi Colorado
Službeni tekst studije (engleski)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Colorado Denver, Aurora
U tijeku regrutacijaFaza 3
Od 40 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Colorado, Denver
- National Jewish Hospital, Denver
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Aurora
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- National Jewish Health, Denver
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- National Jewish Health, Denver
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- University of Colorado Hospital, Aurora
- National Jewish Hospital, Denver
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Colorado - Anschutz Medical Campus, Aurora
- National Jewish Health, Denver
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Colorado | Anschutz Medical Campus, Aurora
U tijeku regrutacijaOpažajna studija
Od 18 do 80 godina · Oba spola · Ažurirano 18. kol 2026. · NCT06855329Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Colorado, Aurora
U tijeku regrutacijaOpažajna studija
Od 21 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of Colorado, Aurora
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07175038An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- National Jewish Health, Denver
U tijeku regrutacijaOpažajna studija
Od 18 do 80 godina · Oba spola · Ažurirano 26. lip 2026. · NCT06129240A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Aurora
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 22. lip 2026. · NCT06576271TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Children's Hospital Colorado, Aurora
U tijeku regrutacijaOpažajna studija
Do 24 godina · Oba spola · Ažurirano 22. lip 2026. · NCT04098445Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- University of Colorado - Anschutz Medical Campus, Aurora
U tijeku regrutacijaOpažajna studija
Od 45 do 90 godina · Oba spola · Ažurirano 1. svi 2026. · NCT03297775Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of Colorado Denver, Aurora
U tijeku regrutacijaOpažajna studija
Od 18 do 90 godina · Oba spola · Ažurirano 3. svi 2024. · NCT06397677Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.